Evaluation of Vertical Bone Gain After Ridge Augmentation With APRF & Xenograft Vs Collagen Membrane & Xenograft. RCT
NCT ID: NCT03855852
Last Updated: 2019-05-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
20 participants
INTERVENTIONAL
2019-02-01
2020-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Alveolar Ridge Preservation Using Different Bone Substitutes
NCT05812872
Vertical and Horizontal Alveolar Ridge Augmentation Using Autogenous Onlay Blocks Combined With Guided Bone Regeneration Using Native Collagen Membrane in Atrophic Anterior Maxilla.
NCT03895060
Ridge Augmentation in Posterior Mandible Using Tunneling Technique With Amix of Autogenous Bone and Xenograft With and Without Collagen Membrane
NCT03712631
Alveolar Ridge Preservation With Layered Collagen and Xenograft
NCT05683509
Injectable Platelets Rich Fibrin Versus Hyaluronic Acid for Alveolar Ridge Preservation
NCT05781529
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Dental implants represent a reliable mean for replacing missing teeth and restoring dental function.
* With increased use of dental implants in replacement of missing teeth in partially edentulous patients the need for implants that satisfy both esthetics and function .
* Thus, the concept of restoration-driven implant placement has been introduced to provide a good match between the position of implant and the future position of the implant supported-restoration to provide a good clinical outcome.
* The concept of prosthetic-driven implant dimensional changes are expected in the hard and soft tissues.
* About 50% of alveolar bone loss occurs in the buccolingual direction in the first 12 months after tooth extraction.
* The alveolar process can be too narrow to facilitate a complete bony surrounding of the placed dental implant.
* Which may lead to a peri-implant bony dehiscence when placing an implant.
* One stage ridge augmentation procedure has been advocated in management of buccal dehiscence and fenestration defects that may develop with implant placement according to prosthetic-driven implant placement concept.
* Guided bone regeneration techniques (GBR) are commonly used in management of these defects.
* However, controversy still exists concerning the complications that may arise such as membrane exposure and its effects on bone regeneration and the possibility of using bone grafts alone to overcome these problems.
* This research promotes the evaluation of A-PRF in combination with xenograft in one stage ridge augmentation.
* The addition of A-PRF to bone grafts has been reported to enhance the process of bone regeneration through different mechanisms.
* Ridge augmentation according to the principle of GBR using collagen membrane and bone graft has been proven to be predictable in producing significant bone gain promoting implant placement.
* The aim of the study is to clinically evaluate vertical bone gain in buccal peri-implant dehiscence and fenestration defects following application of advanced PRF plus xenograft compared to guided bone regeneration using collagen membrane and xenograft.
Surgical procedure:
\- Control group: (Implant placement with xenograft and collagen membrane) After Para crestal incision and raising the mucoperiosteal flap at the top of the alveolar process, the exact position of the dental implant will be defined as determined by preoperative measurements, dental setup, and surgical guide. Bone level implants will be placed 3 mm apical to the expected cervical border of the crown.
The titanium surface of the dental implant will be covered with bone graft (xenograft), and coverage with a resorbable collagen membrane.
-Test group: (implant placement with xenograft and A-PRF) The alveolar bone exposure and implant osteotomy will be prepared and inserted in same manner as in the control group. The titanium surface of the dental implant will be covered with A-PRF and xenograft.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
* A Randomized clinical trial
* Parallel study group
* A trial will be carried out in outpatient clinic of Periodontology Department ,Faculty of Dentistry , Cairo University .
* Equal randomization with equal probabilities for intervention.
* Positive controlled : Both groups will receive treatment
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Xenograft and Collagen membrane
Placing the implant with collagen membrane and xenograft at esthetic zone of maxillary ridge when 2-4 mm of implant threads exposure .
Xenograft and Collagen membrane
Placing the implant with collagen membrane and xenograft at esthetic zone of maxillary ridge with 2-4 mm thread exposure .
Xenograft and A-PRF
Placing the implant with xenograft and A-PRF at esthetic zone of maxillary ridge when 2-4 mm of implant threads exposure .
Xenograft and APRF
Placing the implant with APRF and xenograft at esthetic zone of maxillary ridge with 2-4 mm thread exposure .
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Xenograft and Collagen membrane
Placing the implant with collagen membrane and xenograft at esthetic zone of maxillary ridge with 2-4 mm thread exposure .
Xenograft and APRF
Placing the implant with APRF and xenograft at esthetic zone of maxillary ridge with 2-4 mm thread exposure .
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Systemically healthy.
* Has good dental health.
* Missing a single tooth in the maxillary anterior and premolar region
* Crestal residual ridge width of 4-5mm.
* Residual ridge with an adequate band of keratinized tissue (2 mm).
* Residual ridge with sufficient vertical bone height to safely place a \>10 mm long dental implant.
Exclusion Criteria
* Conditions that complicate wound healing, for example, uncontrolled diabetes (defined as HBA1c level \>7%) or smoking.
* Conditions that might lead to a possibly lowered regenerative capacity of the bone, for example, osteoporosis and Paget's disease.
* Pregnant or expecting to be pregnant.
* History of drug and alcohol abuse or certain medications like bisphosphonates or steroids currently or within the past three months.
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Abdallah waleed sobhi Shbair
Principle Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Abdallah M Shbair, B.D.S
Role: PRINCIPAL_INVESTIGATOR
Dr
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Dentistry , Cairo University
Giza, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CEBD-CU-2019-02-15
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.